Literature DB >> 31061701

Approach to Hyponatremia in Cirrhosis.

Bashar Attar1.   

Abstract

Entities:  

Year:  2019        PMID： 31061701      PMCID： PMC6491031          DOI： 10.1002/cld.790

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  25 in total

1.  Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.

Authors:  Dieter Häussinger
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

Review 2.  The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

3.  Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.

Authors:  Alexander L Gerbes; Veit Gülberg; Pere Ginès; Guy Decaux; Peter Gross; Hassan Gandjini; Jacques Djian
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

4.  Hyponatremia in cirrhosis: Results of a patient population survey.

Authors:  Paolo Angeli; Florence Wong; Hugh Watson; Pere Ginès
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

5.  Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Authors:  Robert W Schrier; Peter Gross; Mihai Gheorghiade; Tomas Berl; Joseph G Verbalis; Frank S Czerwiec; Cesare Orlandi
Journal:  N Engl J Med       Date:  2006-11-14       Impact factor: 91.245

Review 6.  Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.

Authors:  Pere Ginès; Mónica Guevara
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

Review 7.  The management of ascites and hyponatremia in cirrhosis.

Authors:  Pere Ginès; Andrés Cárdenas
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115

8.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

9.  Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.

Authors:  Mónica Guevara; M E Baccaro; Aldo Torre; Beatriz Gómez-Ansón; José Ríos; Ferrán Torres; Lorena Rami; Gemma C Monté-Rubio; Marta Martín-Llahí; Vicente Arroyo; Pere Ginès
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

10.  A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.

Authors:  Florence Wong; Andres T Blei; Laurence M Blendis; Paul J Thuluvath
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425
View more
  6 in total

Review 1.  A narrative review of nutritional abnormalities, complications, and optimization in the cirrhotic patient.

Authors:  Edgewood R Warner; Fuad Z Aloor; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

Review 2.  Management of Portal Hypertension.

Authors:  Anand V Kulkarni; Atoosa Rabiee; Arpan Mohanty
Journal:  J Clin Exp Hepatol       Date:  2022-03-21

3.  Hyponatremia in Chronic Liver Disease among Patients Presenting to a Tertiary Care Hospital: A Descriptive Cross-sectional Study.

Authors:  Abashesh Bhandari; Ashlesha Chaudhary
Journal:  JNMA J Nepal Med Assoc       Date:  2021-12-11       Impact factor: 0.556

4.  Risk factors of the post-reperfusion syndrome during orthotopic liver transplantation: a clinical observational study.

Authors:  Mohammad Ali Sahmeddini; Samaneh Ghazanfar Tehran; Mohammad Bagher Khosravi; Mohammad Hossein Eghbal; Naeimehossadat Asmarian; Fatemeh Khalili; Pooya Vatankhah; Somayeh Izadi
Journal:  BMC Anesthesiol       Date:  2022-04-02       Impact factor: 2.376

5.  Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Zhaohui Bai; Le Wang; Hanyang Lin; Frank Tacke; Gang Cheng; Xingshun Qi
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

Review 6.  Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan.

Authors:  Takuya Adachi; Yasuto Takeuchi; Akinobu Takaki; Atsushi Oyama; Nozomu Wada; Hideki Onishi; Hidenori Shiraha; Hiroyuki Okada
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.